Sign up to save your podcasts
Or
Share A $9 billion biotech deal
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A $9 billion biotech deal
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com.
See omnystudio.com/listener for privacy information.
View all episodes
By GeekWire
4.8
117117 ratings
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com.
See omnystudio.com/listener for privacy information.
More shows like GeekWire
View all
This Week in Startups
1,296 Listeners
WSJ What’s News
4,420 Listeners
Odd Lots
1,993 Listeners
WSJ Tech News Briefing
1,649 Listeners
The Vergecast
3,722 Listeners
The a16z Show
1,105 Listeners
Decoder with Nilay Patel
3,141 Listeners
Masters of Scale
3,992 Listeners
Y Combinator Startup Podcast
233 Listeners
Tech Brew Ride Home
964 Listeners
Big Technology Podcast
512 Listeners
Hard Fork
5,576 Listeners
This Day in AI Podcast
228 Listeners
The AI Daily Brief: Artificial Intelligence News and Analysis
688 Listeners
How I AI
158 Listeners